Montelukast's ability to fight COVID-19 infection

J Asthma. 2021 Oct;58(10):1348-1349. doi: 10.1080/02770903.2020.1786112. Epub 2020 Sep 17.

Abstract

Montelukast can be effective in the treatment of SARS-CoV-2 infection.

Keywords: Prevention; geriatric.

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Acetates / administration & dosage*
  • Aged
  • Aged, 80 and over
  • Anti-Asthmatic Agents / administration & dosage*
  • Asthma / drug therapy*
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology*
  • COVID-19 / prevention & control
  • COVID-19 / virology
  • COVID-19 Serological Testing / statistics & numerical data
  • Case-Control Studies
  • Cyclopropanes / administration & dosage*
  • Female
  • Humans
  • Leukotriene Antagonists / administration & dosage*
  • Male
  • Middle Aged
  • Quinolines / administration & dosage*
  • SARS-CoV-2 / isolation & purification
  • Sulfides / administration & dosage*

Substances

  • Acetates
  • Anti-Asthmatic Agents
  • Cyclopropanes
  • Leukotriene Antagonists
  • Quinolines
  • Sulfides
  • montelukast